$CV The share price has risen by over 100% recently, boosted by the third quarter results and news of the FDA approval application. Given the strong technical indicators, the rally could continue to +15 US dollars.
#stockanalysis
#etfs
#crypto
#tech
#dividends
#nasdaq
#nyse
#dax
#deutschland
#aktien
#aktie
$NOVO B (-0,2 %)
$ONDS (-2,67 %)
$BTC (-0,2 %)
$ETH (+0,65 %)